Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
Pfizer, Inc. | Pfizer | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Purdue Frederick Company Inc. | Purdue Pharma | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000 |
Purdue Pharma | Purdue Pharma | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
Ranbaxy | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,470,000 |
Sanofi US Services, Inc. | Sanofi | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Schering-Plough Corporation | Merck | kickbacks and bribery | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482 |
Schering-Plough Corporation | Merck | off-label or unapproved promotion of medical products | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,756,164 |
Serono Inc. | Merck KGaA (EMD) | off-label or unapproved promotion of medical products | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
SmithKline Beecham Corp. | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
UCB Pharma, Inc. | UCB | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | investor protection violation | 2017 | MULTI-AG | $145,000,000 |
Warner Chilcott Holdings | AbbVie | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Warner Chilcott PLC | AbbVie | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,600,000 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
Wyeth Pharmaceuticals, Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Mallinckrodt | Mallinckrodt | Controlled Substances Act violation | 2020 | MULTI-AG | $1,600,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Indivior plc | Indivior PLC | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $300,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
Endo International plc | Endo International | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $450,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,800,000 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
Hikma Pharmaceuticals | Hikma Pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $150,000,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | environmental violation | 2009 | NC-ENV | $36,836 |
Johnson & Johnson, Inc. | Johnson & Johnson | insurance violation | 2020 | NC-INS | $150,000 |
Janssen Pharmaceuticals/Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Synthes, Inc. | Johnson & Johnson | consumer protection violation | 2009 | NJ-AG | $236,000 |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | environmental violation | 2020 | NJ-ENV | $10,800 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2019 | NJ-ENV | $8,000 |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | environmental violation | 2019 | NJ-ENV | $32,400 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | environmental violation | 2018 | NJ-ENV | $5,850 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2017 | NJ-ENV | $6,000 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | environmental violation | 2016 | NJ-ENV | $22,800 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2016 | NJ-ENV | $19,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2016 | NJ-ENV | $99,800 |
ALCAMI CORPORATION | Alcami | environmental violation | 2014 | NJ-ENV | $11,900 |
E R SQUIBB & SONS LLC | Bristol-Myers Squibb | environmental violation | 2013 | NJ-ENV | $5,950 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | environmental violation | 2011 | NJ-ENV | $25,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2010 | NJ-ENV | $8,000 |
MERCK SHARP & DOHME CORP - RAHWAY NJ | Merck | environmental violation | 2010 | NJ-ENV | $6,000 |
ETHICON INC | Johnson & Johnson | environmental violation | 2009 | NJ-ENV | $5,250 |
MERCK SHARP & DOHME CORP - RAHWAY NJ | Merck | environmental violation | 2009 | NJ-ENV | $8,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2009 | NJ-ENV | $8,900 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | environmental violation | 2009 | NJ-ENV | $10,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2008 | NJ-ENV | $5,600 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | environmental violation | 2007 | NJ-ENV | $9,000 |
IVAX PHARMACEUTICALS INC | Teva Pharmaceutical Industries | environmental violation | 2007 | NJ-ENV | $6,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2007 | NJ-ENV | $15,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2006 | NJ-ENV | $7,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2006 | NJ-ENV | $6,200 |
BRISTOL MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2005 | NJ-ENV | $12,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2005 | NJ-ENV | $31,360 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2005 | NJ-ENV | $23,025 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2003 | NJ-ENV | $28,000 |
MERCK SHARP & DOHME CORP | Merck | environmental violation | 2003 | NJ-ENV | $8,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2003 | NJ-ENV | $14,200 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2003 | NJ-ENV | $14,000 |
HOFFMAN LAROCHE INC | Roche | environmental violation | 2002 | NJ-ENV | $5,000 |
PHARMACIA CORP | Pfizer | environmental violation | 2002 | NJ-ENV | $8,625 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2002 | NJ-ENV | $41,350 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | environmental violation | 2001 | NJ-ENV | $6,000 |
ADVANCED STERILIZATION PRODUCTS INC | Johnson & Johnson | environmental violation | 2023 | NJ-ENV | $13,300 |
MERCK SHARP & DOHME LLC | Merck | environmental violation | 2024 | NJ-ENV | $33,200 |
Parexel International, LLC | Parexel International | labor relations violation | 2012 | NLRB | $253,000 |
Amgen, Inc. | Amgen | labor relations violation | 2011 | NLRB | $40,000 |
Merck and Company, Inc. | Merck | labor relations violation | 2009 | NLRB | $10,710 |
Merck & Co., Inc. | Merck | labor relations violation | 2008 | NLRB | $100,000 |
Schering-Plough | Merck | labor relations violation | 2007 | NLRB | $8,200 |
Boehringer Ingelheim Pharmaceutical, Inc. | Boehringer Ingelheim | labor relations violation | 2004 | NLRB | $50,000 |
Advanced Medical Optics | Abbott Laboratories | labor relations violation | 2004 | NLRB | $16,800 |
Therasense, Inc. | Abbott Laboratories | labor relations violation | 2003 | NLRB | $236,827 |
Mallinckrodt, Inc. | Mallinckrodt | nuclear safety violation | 2000 | NRC | $125,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | NV-AG | $670,000 |
Purdue Frederick Company, Inc. and Purdue Pharma, L.P. | Purdue Pharma | Controlled Substances Act violation | 2007 | NV-AG | $1,047,787 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Abbott Laboratories | Abbott Laboratories | consumer protection violation | 2018 | NY-AG | $50,000 |
Abbott Laboratories, Inc. | Abbott Laboratories | consumer protection violation | 2013 | NY-AG | $25,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
McNeil-PPC, Inc. | Johnson & Johnson | consumer protection violation | 2004 | NY-AG | $52,000 |
Pfizer Inc. | Pfizer | consumer protection violation | 2018 | NY-AG | $700,000 |